Novel Non-Opioid Analgesic Shows Promise in Refractory Cancer Pain

Novel Non-Opioid Analgesic Shows Promise in Refractory Cancer Pain

(MedPage Today) -- Use of the investigational non-opioid analgesic resiniferatoxin appeared to improve pain control in patients with advanced cancer who had intractable pain, though all patients experienced adverse events (AEs), according to an...

New non-opioid painkiller may help stop addiction before it starts

The Food and Drug Administration has approved a new drug called Journavx, which blocks pain signals from getting to the brain. When someone experiences pain, the signal travels from the peripheral nervous system to the brain for processing. Opioids manage pain by blocking pain receptors in the brain. Dr. Jessica McCoun, an anesthesiologist  who worked on the new drug’s clinical trial, said Journavx works on nerves outside the brain, so there’s n…